Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 4233 | 357.005 |
09:34 ET | 520 | 354.63 |
09:41 ET | 429 | 352.16 |
09:45 ET | 200 | 352.16 |
09:48 ET | 1474 | 352.16 |
09:50 ET | 578 | 350.8089 |
09:52 ET | 677 | 351.18 |
09:54 ET | 800 | 349.455 |
09:56 ET | 1156 | 347.83 |
09:57 ET | 2969 | 347.25 |
09:59 ET | 1539 | 347 |
10:01 ET | 400 | 347.765 |
10:03 ET | 753 | 348.37 |
10:08 ET | 600 | 348.505 |
10:10 ET | 1100 | 348.57 |
10:12 ET | 2135 | 349.78 |
10:14 ET | 400 | 350.4 |
10:15 ET | 200 | 350.45 |
10:17 ET | 2977 | 351.84 |
10:19 ET | 279 | 351.84 |
10:21 ET | 400 | 353.03 |
10:24 ET | 400 | 352.77 |
10:26 ET | 637 | 353.49 |
10:28 ET | 400 | 353.045 |
10:30 ET | 1400 | 353.64 |
10:32 ET | 400 | 354.32 |
10:33 ET | 200 | 354.78 |
10:35 ET | 1548 | 354.9 |
10:37 ET | 300 | 355.11 |
10:39 ET | 400 | 355.59 |
10:42 ET | 300 | 355.155 |
10:44 ET | 100 | 355.59 |
10:46 ET | 400 | 355.285 |
10:48 ET | 1200 | 355.51 |
10:51 ET | 400 | 355.515 |
10:53 ET | 500 | 355.51 |
10:55 ET | 4299 | 355.96 |
11:00 ET | 500 | 356.795 |
11:02 ET | 964 | 356.48 |
11:04 ET | 500 | 356.87 |
11:06 ET | 139 | 357.06 |
11:08 ET | 2102 | 357.24 |
11:09 ET | 100 | 357.14 |
11:11 ET | 100 | 356.91 |
11:13 ET | 100 | 356.885 |
11:15 ET | 200 | 356.885 |
11:22 ET | 100 | 356.875 |
11:26 ET | 400 | 356.82 |
11:27 ET | 101 | 356.92 |
11:29 ET | 100 | 356.87 |
11:33 ET | 1200 | 357.335 |
11:40 ET | 936 | 357.77 |
11:42 ET | 900 | 357.91 |
11:45 ET | 600 | 357.71 |
11:47 ET | 600 | 357.8165 |
11:49 ET | 278 | 357.675 |
11:51 ET | 1500 | 357.245 |
11:58 ET | 1000 | 356.97 |
12:00 ET | 800 | 356.44 |
12:02 ET | 100 | 356.365 |
12:03 ET | 127 | 356.475 |
12:07 ET | 200 | 356.25 |
12:09 ET | 6217 | 356.37 |
12:12 ET | 2497 | 356.08 |
12:14 ET | 800 | 356.15 |
12:16 ET | 400 | 356.185 |
12:18 ET | 600 | 356.315 |
12:20 ET | 303 | 356.22 |
12:25 ET | 400 | 356.025 |
12:30 ET | 335 | 355.61 |
12:32 ET | 100 | 355.465 |
12:34 ET | 100 | 355.655 |
12:38 ET | 400 | 355.39 |
12:39 ET | 350 | 355.56 |
12:41 ET | 100 | 355.56 |
12:43 ET | 1129 | 355.88 |
12:45 ET | 100 | 355.99 |
12:48 ET | 100 | 355.865 |
12:50 ET | 200 | 355.865 |
12:56 ET | 1357 | 356.09 |
12:57 ET | 804 | 355.77 |
12:59 ET | 658 | 355.3 |
01:01 ET | 945 | 355.28 |
01:03 ET | 100 | 355.45 |
01:06 ET | 300 | 355.06 |
01:08 ET | 2049 | 355.88 |
01:10 ET | 608 | 355.788 |
01:12 ET | 600 | 355.47 |
01:14 ET | 543 | 355.4 |
01:15 ET | 701 | 355.195 |
01:17 ET | 100 | 355.155 |
01:24 ET | 300 | 355.175 |
01:26 ET | 809 | 355.545 |
01:28 ET | 100 | 355.535 |
01:32 ET | 300 | 355.52 |
01:33 ET | 1700 | 355.39 |
01:37 ET | 500 | 355.9 |
01:39 ET | 363 | 355.75 |
01:42 ET | 100 | 355.745 |
01:46 ET | 300 | 355.9415 |
01:48 ET | 100 | 355.755 |
01:51 ET | 1387 | 356.29 |
01:53 ET | 700 | 356.23 |
01:55 ET | 600 | 356.61 |
01:57 ET | 420 | 356.4967 |
02:00 ET | 100 | 356.72 |
02:02 ET | 1606 | 356.96 |
02:04 ET | 100 | 356.865 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 15.8B | 16.4x | +8.22% |
Biomarin Pharmaceutical Inc | 13.2B | 51.9x | --- |
Exact Sciences Corp | 12.9B | -71.6x | --- |
Neurocrine Biosciences Inc | 11.9B | 35.2x | +62.04% |
Beigene Ltd | 22.2B | -41.4x | --- |
Medpace Holdings Inc | 11.2B | 33.6x | +35.10% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.8B |
---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 16.4x |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | 14.0x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.